Automatic Website Traffic RSS

FDA greenlights first nonopioid drug for opioid withdrawal - Becker's Hospital Review

The FDA approved Lucemyra, the first nonopioid treatment for adults managing opioid withdrawal symptoms, the agency announced May 16. Lucemyra is an oral medication that reduces the release of ... read more

FDA greenlights first nonopioid drug for opioid withdrawal

The FDA approved Lucemyra, the first nonopioid treatment for adults managing opioid withdrawal symptoms, the agency announced May 16. Lucemyra is an oral medication that reduces the release of ... read more

FDA approves first non-opioid withdrawal treatment - UPI.com

May 17 (UPI) --The U.S. Food and Drug Administration said it's approved for the first time a non-opioid drug for treatment of opioid withdrawal.The FDA said the drug Lucemyra, made by US WorldMeds ... read more

Nonopioid drug approved by FDA for opioid withdrawal symptoms

TRENTON, N.J. -- Federal regulators on Wednesday approved the first nonopioid treatment to ease withdrawal from quitting addictive opioids. The U.S. Food and Drug Administration expedited approval ... read more

FDA approves non-opioid drug to treat opioid withdrawal symptoms

Federal regulators on Wednesday approved the first nonopioid treatment to ease withdrawal from quitting addictive opioids. The U.S. Food and Drug Administration expedited approval of Lucemyra to ... read more

FDA approves first non-opioid to treat withdrawal symptoms - NBC News

It's the first non-opioid for treating withdrawal symptoms. US WorldMeds May 17, 2018, 10:14 AM EDT / Updated May 17, 2018, 10:21 AM EDT / Source : The Associated Press ... read more

FDA approves first non-opioid agent for regulating opioid withdrawal symptoms - Healio

Today the FDA announced its approval of Lucemyra, the first non-opioid treatment for lessening the severity of opioid withdrawal symptoms, such as anxiety, agitation, sleep issues, nausea and ... read more

FDA approves the first non-opioid treatment for management of opioid withdrawal symptoms in adults - Markets Insider

SILVER SPRING, Md., May 16, 2018 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today approved Lucemyra (lofexidine hydrochloride) for the mitigation of withdrawal symptoms to ... read more

FDA Approves First Nonopioid Treatment for Opioid Withdrawal Symptoms - WSJ - The Wall Street Journal

The U.S. Food and Drug Administration has approved the first nonopioid treatment to help adults manage opioid withdrawal symptoms as the agency looks to continue to encourage the development of ... read more

FDA OKs first non-opioid drug for adults with opioid withdrawal symptoms - News-Medical.net

The United States Food and Drugs Administration (FDA), in a statement this week, approved a new drug Lucemyra (lofexidine hydrochloride) for the treatment and alleviation of opioid symptom ... read more

First Non-Opioid Drug Approved for Managing Opioid Withdrawal Symptoms

The Food and Drug Administration (FDA) has approved Lucemyra (lofexidine HCl; US WorldMeds) for the mitigation of opioid withdrawal symptoms to facilitate abrupt opioid discontinuation in adults. read more

FDA Approves First Nonopioid Drug for Opioid Withdrawal - Medscape

The US Food and Drug Administration (FDA) has approved lofexidine hydrochloride (Lucemyra, US WorldMeds), a nonopioid, for the mitigation of symptoms in the setting of abrupt opioid withdrawal in ... read more